Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 11,867 | 13,542 | 20,099 | 12,053 | 13,206 |
| Cost of Goods | 4,520 | 4,437 | 4,526 | 4,389 | 4,679 |
| Gross Profit | 7,347 | 9,105 | 15,573 | 7,664 | 8,527 |
| Operating Expenses | 21,446 | 17,832 | 16,044 | 17,010 | 13,117 |
| Operating Income | -13,579 | -8,290 | 55 | -8,957 | -3,911 |
| Interest Expense | 4,224 | 4,198 | 4,195 | 4,200 | 3,235 |
| Other Income | 734 | 979 | 1,395 | 329 | -864 |
| Pre-tax Income | -17,069 | -11,509 | -2,745 | -12,828 | -8,010 |
| Income Tax | N/A | N/A | N/A | N/A | 101 |
| Net Income Continuous | -17,055 | -11,509 | -2,745 | -12,828 | -8,111 |
| Net Income | $-17,055 | $-11,509 | $-2,745 | $-12,828 | $-8,111 |
| EPS Basic Total Ops | -0.18 | -0.13 | -0.03 | -0.17 | -0.15 |
| EPS Basic Continuous Ops | -0.18 | -0.13 | -0.03 | -0.17 | -0.14 |
| EPS Diluted Total Ops | -0.18 | -0.13 | -0.03 | -0.17 | -0.11 |
| EPS Diluted Continuous Ops | -0.18 | -0.13 | -0.03 | -0.17 | -0.11 |
| EPS Diluted Before Non-Recurring Items | -0.19 | -0.13 | -0.03 | N/A | N/A |
| EBITDA(a) | $-10,733 | $-5,458 | $2,929 | $-6,077 | $-1,646 |